Atlas Trials

Safety and Immunogenicity Study of a DNA Priming and MVA Boosting Strategy of HIV Vaccine

Clinical trial NCT01407497 · COMPLETED

Trial details

NCT number
NCT01407497
Sponsor
Instituto Nacional de Saúde, Mozambique
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV Infections
Start date
2011-08-01
Primary completion
2013-03-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.